Show simple item record

dc.contributor.authorMcDonnell, Barry J.
dc.contributor.authorSchutte, Alta E.
dc.contributor.authorKeitley, James
dc.contributor.authorBeaney, Thomas
dc.contributor.authorTay, Tricia
dc.date.accessioned2019-08-20T12:06:35Z
dc.date.available2019-08-20T12:06:35Z
dc.date.issued2019
dc.identifier.citationMcDonnell, B.J. et al. 2019. May Measurement Month 2017: an analysis of blood pressure screening results from the United Kingdom and the Republic of Ireland-Europe. European heart journal supplements, 21 (Suppl D):D121-D123. [https://doi.org/10.1093/eurheartj/suz072]en_US
dc.identifier.issn1520-765X
dc.identifier.issn1554-2815 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/33235
dc.identifier.urihttps://academic.oup.com/eurheartjsupp/article-pdf/21/Supplement_D/D121/28502419/suz072.pdf
dc.identifier.urihttps://doi.org/10.1093/eurheartj/suz072
dc.description.abstractElevated blood pressure (BP), or hypertension, is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative aimed at raising awareness of high BP and acting as a stimulus to improving screening programmes worldwide. In the United Kingdom (UK) nearly 1 in 5 people, and in the Republic of Ireland (RoI) 3 out of 10, have hypertension, of which a large proportion remains undiagnosed. An opportunistic cross-sectional survey of volunteers aged ≥18 years was carried out in May 2017. Blood pressure measurement, the definition of hypertension and statistical analysis followed a standardized protocol. Screenings sites in hospitals, universities, shopping centres, workplaces, sports clubs, community centres, GP practices, and pharmacies were set up across the UK and RoI as part of this initiative. Seven thousand seven hundred and fourteen individuals were screened during MMM17. After multiple imputation, 3099 (40.3%) had hypertension. Of individuals not receiving antihypertensive medication, 1406 (23.4%) were hypertensive. Of individuals receiving antihypertensive medication, 682 (40.5%) had uncontrolled BP. MMM17 was the largest BP screening campaign ever undertaken in the UK and RoI. These data prove for the first time that a relatively inexpensive, volunteer based, convenience sampling of screening BP in the community identified two out of five individuals as hypertensive, with one in four not receiving treatment. Of major concern is that these data demonstrate that of those individuals receiving treatment, two out of five still did not have controlled BPen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.subjectAntihypertensive agentsen_US
dc.subjectHypertensionen_US
dc.subjectBlood pressure determinationen_US
dc.subjectIrelanden_US
dc.subjectPharmaciesen_US
dc.subjectSportsen_US
dc.subjectWorkplaceen_US
dc.subjectScreeningen_US
dc.subjectHypertension screeningen_US
dc.subjectCommunityen_US
dc.subjectUndiagnoseden_US
dc.subjectMultiple imputationen_US
dc.titleMay Measurement Month 2017: an analysis of blood pressure screening results from the United Kingdom and the Republic of Ireland-Europeen_US
dc.typeArticleen_US
dc.contributor.researchID10922180 - Schutte, Aletta Elisabeth


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record